Neuroprotection after oxygen shortage in the brain

Neurophyxia is an innovative clinical drug development company developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain. Our lead product 2-IB  is currently in Phase II Clinical Trials for 3 indications:

  • Stroke in adults
  • Cardiac Arrest in adults
  • Birth Asphyxia in newborns.